Vigabatrin‐associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

VABAM are common in VGB-treated TSC infants; however, VABAM-like abnormalities also occurred in children without either VGB or TSC. The cause of these MRI changes is unknown. Possible contributing factors are abnormal myelination, underlying etiology, recurrent seizures, and other antiseizure medication. Furthermore, the presence of VABAM (or VABAM-like abnormalities) did not appear to be associated with clinical symptoms. This study confirms that the well-known antiseizure effects of VGB outweigh the risk of VABAM and related symptoms.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2024-12-06
DOI
https://doi.org/10.1111/epi.18190
Citations
4
Primary Topic
Tuberous Sclerosis Complex Research
Type
article
Field-Weighted Citation Impact
1.31

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vigabatrin‐associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

Krzysztof Sadowski, Eleonora Aronica, Kinga Szczepaniak, Floor E. Jansen et al.
4 citations
Epilepsia
Tuberous Sclerosis Complex Research
1.31
article

Vigabatrin‐associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

Krzysztof Sadowski, Eleonora Aronica, Kinga Szczepaniak, Floor E. Jansen, Julita Borkowska, Sergiusz Jóźwiak, Rima Nabbout, Willem M. Otte, Anna Jansen, Pavel Kršek, Katarzyna Kotulska, Alexander Leemans, Miroslav Maminak, Alberto De Luca, Jessie De Ridder, Christoph Hertzberg, Maarten H. Lequin, Theresa O. Scholl, Konrad Wojdan, Hanna M. Hulshof, Dorota Domańska‐Pakieła, Jagoda Głowacka‐Walas, Kees P. J. Braun, Martha Feucht, Kamil Sijko, B. Petrák, Paolo Curatolo, Bernhard Weschke, Romina Moavero, Kate Riney, Lieven G. Lagae, Carmen H. Stevering, Saba Ishrat, David J. Kwiatkowski
article en
4 citations

Abstract

VABAM are common in VGB-treated TSC infants; however, VABAM-like abnormalities also occurred in children without either VGB or TSC. The cause of these MRI changes is unknown. Possible contributing factors are abnormal myelination, underlying etiology, recurrent seizures, and other antiseizure medication. Furthermore, the presence of VABAM (or VABAM-like abnormalities) did not appear to be associated with clinical symptoms. This study confirms that the well-known antiseizure effects of VGB outweigh the risk of VABAM and related symptoms.

EpilepsiaVol. 66(2)
University of Rome Tor Vergata (IT), Brigham and Women's Hospital (US), Vrije Universiteit Brussel (BE), Harvard University (US), University of Antwerp (BE), Université Paris Cité (FR), Charles University (CZ), University Medical Center Utrecht (NL), University Hospital in Motol (CZ), Amsterdam Neuroscience (NL), Children's Memorial Health Institute (PL), Bambino Gesù Children's Hospital (IT), Transition Technologies (Poland) (PL), Institut des Maladies Génétiques Imagine (FR), Children's Health Queensland Hospital and Health Service (AU), Medical University of Vienna (AT), Charité - Universitätsmedizin Berlin (DE), University of Amsterdam (NL), KU Leuven (BE)
European Commission, Agencja Badań Medycznych
Good health and well-being
Openalex Percentile: Top 18%
Tuberous Sclerosis Complex Research
1.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.